Samsung Genome Institute

Enabling Precision Medicine for the benefit of our patients and world-class research in genomics

Introduction

Samsung Genome Institute was launched in March 2013 to develop a comprehensive system for the implementation of precision cancer medicine based on genome sequencing and analysis.

In order to provide personalized treatment to cancer patients, various kinds of genome research are performed in collaboration with multiple specialists and clinicians in the fields of cancer genomics, bioinformatics and functional genomics.

Strengths of Samsung Genome Institute

  • Operates the highest global standards level of genome analysis infrastructure
  • Establishes a next-generation personalized treatment system based on genomic information
  • Endeavors to improve the quality of life of patients, increase treatment performance and reduce medical costs by utilizing a world-class genome-based personalized treatment system that draws on global research capabilities and core genome technology.

Major Achievements

  • Expanded infrastructure for early phase through cancer clinical trial ward
  • Continuously hosted clinical trial business fairs to establish networks with pharmaceutical companies and CROs

Contact

  • TEL
    82-2-2148-9814 tel
close

患者的权利和责任

Patients' Rights

1. Right to receive medical care

Patients have the right to receive proper medical and nursing services for their Health Protection and Promotion and they will not be discriminated for gender, age, religion, status, nationality, language, race, or physical/mental/financial circumstances nor be violated of their health. Medical team may not deny medical care without justifiable reason.

2. Right to be informed & autonomous decision

Patients have the right to receive be well-informed and to inquire in detail about the treating physician’s specialty, status of their disease, purpose of the treatment, treatment plan, method, expected results and side effects of the treatment, discharge plan, medical cost, whether or not they are a subject to medical research, organ transplant/donation and etc, and to decide whether to give consent. Patients may stop or deny specific treatment or planned medical care within the ethical guideline and may decide on an alternative treatment.

3. Right to have confidentiality

Patients will not be violated of their rights to confidentiality regarding their physical/health status and privacy. Medical team and facility may not reveal or announce patient’s confidential information, including personal information, unless patient has gives consent or specified in the law, such as criminal investigation.

4. Right to request for consultation and mediation

Patients may request for consultation and mediation from an internal or external agency (Korea Consumer Agency, Korea Medical Dispute Mediation and Arbitration Agency) in the event of any medical dispute.

5. Right to be respected of values or beliefs

Patients will not be discriminated for their culture, religious values or beliefs, and their rights will not be violated.

6. Right to be physically protected and to have stability of mind and bod

Patients have the right to be protected from possible danger in the hospital and to have the stability of mind and body.

Patients’Responsibilities

1. Responsible to trust and respect the medical team

Patients must accurately inform the medical team of their health condition, trust and respect the medical team’s treatment plan. Patients may be responsible for consequences which results from not following the instruction.

2. Responsible to not use dishonest method for medical treatment

Patients must reveal their identity before receiving any medical care and must not use false or dishonest method, such as receiving medical case under disguised ownership.

3. Responsible to abide by all hospital regulations

Patients must abide by all hospital regulations, respect hospital staff and other patients, and earnestly fulfill the financial obligation to the hospital.